270 related articles for article (PubMed ID: 35256302)
1. PET/CT: Radiation Therapy Planning in Head and Neck Cancer.
Eraj S; Sher DJ
PET Clin; 2022 Apr; 17(2):297-305. PubMed ID: 35256302
[TBL] [Abstract][Full Text] [Related]
2. Adaptive 18fluoro-2-deoxyglucose positron emission tomography/computed tomography-based target volume delineation in radiotherapy planning of head and neck cancer.
Moule RN; Kayani I; Prior T; Lemon C; Goodchild K; Sanghera B; Wong WL; Saunders MI
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):364-71. PubMed ID: 21109410
[TBL] [Abstract][Full Text] [Related]
3. Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions.
Mohamed ASR; Cardenas CE; Garden AS; Awan MJ; Rock CD; Westergaard SA; Brandon Gunn G; Belal AM; El-Gowily AG; Lai SY; Rosenthal DI; Fuller CD; Aristophanous M
Radiother Oncol; 2017 Aug; 124(2):248-255. PubMed ID: 28774596
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
5. Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary?
Fried D; Lawrence M; Khandani AH; Rosenman J; Cullip T; Chera BS
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):748-54. PubMed ID: 22414285
[TBL] [Abstract][Full Text] [Related]
6. A new role of PET/CT for target delineation for radiotherapy treatment planning for head and neck carcinomas.
Zygogianni A; Kyrgias G; Kouvaris J; Pistevou-Gompaki K; Kouloulias V
Hell J Nucl Med; 2012; 15(2):139-43. PubMed ID: 22833861
[TBL] [Abstract][Full Text] [Related]
7. Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours.
Troost EG; Schinagl DA; Bussink J; Oyen WJ; Kaanders JH
Radiother Oncol; 2010 Sep; 96(3):328-34. PubMed ID: 20708808
[TBL] [Abstract][Full Text] [Related]
8.
van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
[TBL] [Abstract][Full Text] [Related]
9. "Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer": in regard to Guido et al. (Int J Radiat Oncol Biol Phys 2009;73:759-763).
Schinagl DA; Troost EG; Kaanders JH
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1629; author reply 1629. PubMed ID: 19515513
[No Abstract] [Full Text] [Related]
10. Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer.
Guido A; Fuccio L; Rombi B; Castellucci P; Cecconi A; Bunkheila F; Fuccio C; Spezi E; Angelini AL; Barbieri E
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):759-63. PubMed ID: 18834671
[TBL] [Abstract][Full Text] [Related]
11. Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers.
Henriques de Figueiredo B; Barret O; Demeaux H; Lagarde P; De-Mones-Del-Pujol E; Kantor G; de Clermont-Gallerande H; Richaud P; Fernandez P
Radiother Oncol; 2009 Dec; 93(3):479-82. PubMed ID: 19880207
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic optimization in head and neck radiotherapy planning: Advocacy for
Nevesny S; Flaus A; Ailloud A; Sotton S; Prevot N; Guy JB; Magné N
Bull Cancer; 2022 Dec; 109(12):1262-1268. PubMed ID: 36283891
[TBL] [Abstract][Full Text] [Related]
13.
Farina E; Ferioli M; Castellucci P; Farina A; Zanirato Rambaldi G; Cilla S; Cammelli S; Fanti S; Morganti AG
Anticancer Res; 2017 Dec; 37(12):6523-6532. PubMed ID: 29187426
[TBL] [Abstract][Full Text] [Related]
14. Workflow and radiation safety implications of (18)F-FDG PET/CT scans for radiotherapy planning.
Sam S; Shon IH; Vinod SK; Lin P; Lin M
J Nucl Med Technol; 2012 Sep; 40(3):175-7. PubMed ID: 22582005
[TBL] [Abstract][Full Text] [Related]
15. Role of PET/CT in treatment planning for head and neck cancer patients undergoing definitive radiotherapy.
Arslan S; Abakay CD; Sen F; Altay A; Akpinar T; Ekinci AS; Esbah O; Uslu N; Kekilli KE; Ozkan L
Asian Pac J Cancer Prev; 2014; 15(24):10899-903. PubMed ID: 25605198
[TBL] [Abstract][Full Text] [Related]
16. Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
Cardoso M; Min M; Jameson M; Tang S; Rumley C; Fowler A; Estall V; Pogson E; Holloway L; Forstner D
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):399-407. PubMed ID: 30816646
[TBL] [Abstract][Full Text] [Related]
17. [18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer.
El-Bassiouni M; Ciernik IF; Davis JB; El-Attar I; Reiner B; Burger C; Goerres GW; Studer GM
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):286-93. PubMed ID: 17707283
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET/CT in radiation treatment planning of head and neck squamous cell carcinoma.
Arens AI; Troost EG; Schinagl D; Kaanders JH; Oyen WJ
Q J Nucl Med Mol Imaging; 2011 Oct; 55(5):521-8. PubMed ID: 22019709
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography/computed tomography for target delineation in head and neck cancers.
Ahn PH; Garg MK
Semin Nucl Med; 2008 Mar; 38(2):141-8. PubMed ID: 18243850
[TBL] [Abstract][Full Text] [Related]
20. [PET/CT based radiotherapy treatment planning in head and neck cancers].
Sinkó D; Klinkó T; Weisz C; Nemeskéri C; Fekésházy A; Tóth V; Tóth Z; Mayer A
Orv Hetil; 2009 Jul; 150(30):1403-6. PubMed ID: 19592335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
